Chimeric antigen receptor-engineered NK cells: new weapons of cancer immunotherapy with great potential

Chimeric antigen receptor (CAR)-engineered T (CAR-T) cells have obtained prominent achievement in the clinical immunotherapy of hematological malignant tumors, leading to a rapid development of cellular immunotherapy in cancer treatment. Scientists are also aware of the prospective advantages of CAR...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiao, Yang, Xuejiao, Yuan, Xiang, Wang, Wenbo, Wang, Yueying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628181/
https://www.ncbi.nlm.nih.gov/pubmed/36324149
http://dx.doi.org/10.1186/s40164-022-00341-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628181/
https://www.ncbi.nlm.nih.gov/pubmed/36324149
http://dx.doi.org/10.1186/s40164-022-00341-7

Ejemplares similares